CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: May 7, 2008
Result type: Reports
Project Number: SR0136-000
Product Line: Reimbursement Review

Generic Name: Maraviroc

Brand Name: Celsentri

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: HIV

Indications: HIV

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: November 12, 2008

Recommendation Type: List with clinical criteria and/or conditions